Related Experiment Video
Updated: Feb 9, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
MicroRNA-3200-5p Promotes Osteosarcoma Cell Invasion via Suppression of BRMS1
1Department of Orthopedics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
Abstract:
Tumour metastasis is one of the most serious challenges of cancer as it is the major cause of mortality in patients with solid tumours, including osteosarcoma (OS). In this regard, anti-metastatic genes have potential for metastasis inhibition strategies. Recent evidence showed the importance of breast cancer metastasis suppressor 1 (BRMS1) in control of OS invasiveness, but the regulation of BRMS1 in OS remains largely unknown. Here, we used bioinformatics analyses to predict BRMS1-targeting microRNAs (miRNAs), and the functional binding of miRNAs to BRMS1 mRNA was evaluated using a dual luciferase reporter assay. Among all BRMS1-targeting miRNAs, only miR-151b, miR-7-5p and miR-3200-5p showed significant expression in OS specimens. Specifically, we found that only miR-3200-5p significantly inhibited protein translation of BRMS1 via pairing to the 3'-UTR of the BRMS1 mRNA. Moreover, we detected significantly lower BRMS1 and significantly higher miR-3200-5p in the OS specimens compared to the paired adjacent non-tumour bone tissues. Furthermore, BRMS1 and miR-3200-5p levels were inversely correlated to each other. Low BRMS1 was correlated with metastasis and poor patient survival. In vitro, overexpression of miR-3200-5p significantly decreased BRMS1 levels and promoted OS cell invasion and migration, while depletion of miR-3200-5p significantly increased BRMS1 levels and inhibited OS cell invasion and migration. Thus, our study revealed that miR-3200-5p may be a critical regulator of OS cell invasiveness.
Insights
This study identifies miR-3200-5p as a key regulator of osteosarcoma (OS) metastasis. It found that higher miR-3200-5p levels correlate with lower breast cancer metastasis suppressor 1 (BRMS1) expression, promoting OS cell invasiveness.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Tumour metastasis, particularly in osteosarcoma (OS), is a primary cause of cancer mortality.
- Breast cancer metastasis suppressor 1 (BRMS1) is implicated in controlling OS invasiveness, but its regulatory mechanisms in OS are not well understood.
Purpose of the Study:
- To investigate the role of microRNAs (miRNAs) in regulating BRMS1 expression in osteosarcoma.
- To determine the functional impact of miR-3200-5p on OS cell invasion and migration.
Main Methods:
- Bioinformatic analysis to predict miRNAs targeting BRMS1.
- Dual luciferase reporter assays to validate miRNA-mRNA binding.
- Quantitative analysis of BRMS1 and miR-3200-5p expression in OS tissues.
- In vitro cell culture experiments to assess the effects of miR-3200-5p modulation on OS cell behavior.
Main Results:
- miR-3200-5p was identified as a direct inhibitor of BRMS1 translation by binding to its 3'-UTR.
- OS tissues exhibited significantly lower BRMS1 and higher miR-3200-5p levels compared to adjacent non-tumour tissues.
- BRMS1 and miR-3200-5p levels were inversely correlated; low BRMS1 correlated with metastasis and poor survival.
- Overexpression of miR-3200-5p promoted OS cell invasion and migration, while its depletion inhibited these processes.
Conclusions:
- miR-3200-5p acts as a tumor suppressor by downregulating BRMS1 in osteosarcoma.
- miR-3200-5p is a critical regulator of osteosarcoma cell invasiveness and holds potential as a therapeutic target.
Related Concept Videos
MicroRNAs
MicroRNAs
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Anaphase Promoting Complex
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results...

